TITLE

Pathwork Diagnostics Lab Awarded CAP Accreditation

PUB. DATE
April 2011
SOURCE
Clinical Lab Products;Apr2011, Vol. 41 Issue 4, p24
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article announced that the College of American Pathologists (CAP) has accredited the laboratory of Pathwork Diagnostics Inc., a molecular diagnostics company focused on oncology.
ACCESSION #
60636088

 

Related Articles

  • Pathwork Diagnostics Laboratory Awarded Accreditation from College of American Pathologists.  // Biomedical Market Newsletter;4/30/2011, p280 

    The article reports on the accreditation received by the laboratory of Pathwork Diagnostics Inc. from the College of American Pathologists (CAP) in 2011. The Pathwork Tissue of Origin Test of the company, provided by the Pathwork Diagnostics Laboratory, helps distinguish the origin of metastatic...

  • GENE TESTING OF FLUID SPECIMENS IDENTIFIES CANCER ORIGEN.  // Biotech Business;Apr2011, Vol. 24 Issue 4, p6 

    The article deals with the results of a study on Pathwork Diagnostics Incorporated's Tissue of Origin Test for various formalin-fixed, paraffin-embedded (FFPE) fluid specimens conducted in the U.S. The molecular test assists in determining the origin of metastatic tumors accurately. It measures...

  • Pathwork, Novartis to work on cancer research.  // Medical Device Daily;8/2/2010, Vol. 14 Issue 148, p4 

    The article reports on a research collaboration formed by Pathwork Diagnostics with Novartis.

  • Pathwork Diag completes $30 million Series C Round.  // Medical Device Daily;10/7/2010, Vol. 14 Issue 195, p4 

    The article reports on the completion of the 30 million-dollar Alta Partners-led Series C financing of Pathwork Diagnostics, a privately held molecular diagnostics company focused on oncology.

  • FCAP.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p853 

    An encyclopedia entry for FCAP which stands for Fellow of the College of American Pathologists is presented.

  • Worth noting.  // MLO: Medical Laboratory Observer;Jan2010, Vol. 42 Issue 1, p6 

    The article offers information related to innovations in medical science, which includes laboratories accredited by the College of American Pathologists would also have a certification mark.

  • Pathwork Diagnostics launches version of its tissue of origin test for FFPE specimens.  // Hem/Onc Today;3/10/2009, Vol. 10 Issue 5, p50 

    The article announces the launching of an additional version of the Pathwork Tissue of Origin Test from Pathwork Diagnostics Inc.

  • Pathwork's test to ID tumor types validated in large study. YOFFEE, LYNN // Medical Device Daily;4/1/2009, Vol. 13 Issue 61, p1 

    The article reports that a study has given strong validation to a test developed by Pathwork Diagnostics designed to help physicians reduce diagnostic uncertainty for tumors of uncertain origin. It was mentioned that the company's Pathwork Tissue of Origin Test uses a microarray to measure the...

  • Pathwork rolls out 'frozen' version for Tissue of Origin. FORD, OMAR // Medical Device Daily;1/23/2009, Vol. 13 Issue 14, p1 

    The article focuses on the development of an additional version of Pathwork Diagnostics' Tissue of Origin Test. Using a microarray to analyze the expression pattern, the company created the test which comprises of more than 1,500 genes in the uncertain tumor and compares it to the expression...

  • Product Briefs.  // Medical Device Daily;1/26/2011, Vol. 15 Issue 17, p5 

    The article offers information on the violet laser diode developed by Opnext for biomedical illumination applications and the results from a decision impact study of Pathwork Diagnostics' Tissue of Origin Test.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics